Floatz logo

Docetaxel

Periampullary Cancer

Minia UniversitySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Periampullary Cancer cohort.

Asset / SponsorPhaseRating
N-BUTYL CYANOACRYLATE
Minia University
Phase 3BB
Epirubicin
Minia University
Phase 3B
Cipralex
Case Comprehensive Cancer Center
Phase 2CCC
Ethiodized Oil
Minia University
Phase 1CC
Tezemlimogene Daxadenorepvec
DNAtrix, Inc.
Phase 1CC

Same molecule, other indications

Docetaxel is also rated in:

prostate neoplasmDormant
BBB
Indicative ·
73 / 100
View asset →
pancreatic adenocarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →